相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Conjoint Effects of Serum Calcium and Phosphate on Risk of Total, Cardiovascular, and Noncardiovascular Mortality in the Community
Tobias E. Larsson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
James B. Wetmore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Association of Dietary Phosphorus Intake and Phosphorus to Protein Ratio with Mortality in Hemodialysis Patients
Nazanin Noori et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
Tobias E. Larsson
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Sarah Seiler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Epidemiology of Incident Heart Failure in a Contemporary Elderly Cohort The Health, Aging, and Body Composition Study
Andreas Kalogeropoulos et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
Renata C. Pereira et al.
BONE (2009)
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Marcello Tonelli et al.
CIRCULATION (2009)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
Phosphate Levels and Cardiovascular Disease in the General Population
Robert N. Foley
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Longitudinal Relationships among Coronary Artery Calcification, Serum Phosphorus, and Kidney Function
Katherine R. Tuttle et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2009)
Chronic kidney disease, hypovitaminosis D, and mortality in the United States
Rajnish Mehrotra et al.
KIDNEY INTERNATIONAL (2009)
Vitamin D levels and patient outcome in chronic kidney disease
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2009)
Relationship between circulating FGF23 and total body atherosclerosis in the community
Majd A. I. Mirza et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: The Atherosclerosis Risk in Communities (ARIC) Study
Robert N. Foley et al.
AMERICAN HEART JOURNAL (2008)
Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study
Ron Wald et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality
Harald Dobnig et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function
Marcel Roos et al.
CLINICAL ENDOCRINOLOGY (2008)
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Vitamin D levels and early mortality among incident hemodialysis patients
M. Wolf et al.
KIDNEY INTERNATIONAL (2007)
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
Scott D. Solomon et al.
CIRCULATION (2007)
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
Ravi Dhingra et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Y. Nishida et al.
KIDNEY INTERNATIONAL (2006)
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats
N Nagano et al.
KIDNEY INTERNATIONAL (2006)
FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation
Sangeeta Pande et al.
NEPHRON PHYSIOLOGY (2006)
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
M Tonelli et al.
CIRCULATION (2005)
Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules
M Baum et al.
KIDNEY INTERNATIONAL (2005)
Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23
K Miyamoto et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan
F Koiwa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Serum phosphate levels and mortality risk among people with chronic kidney disease
B Kestenbaum et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal election fraction
JE Rame et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Heart failure in pressure overload hypertrophy - The relative roles of ventricular remodeling and myocardial dysfunction
GR Norton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
RB Devereux et al.
BLOOD PRESSURE (2001)
分享论文
